BNP Paribas Financial Markets’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.5M Buy
91,254
+34,295
+60% +$14.4M 0.01% 849
2026
Q1
$21.5M Buy
56,959
+21,935
+63% +$9.39M 0.01% 1107
2025
Q4
$15M Buy
35,024
+4,430
+14% +$1.93M 0.01% 1365
2025
Q3
$13.7M Sell
30,594
-9,846
-24% -$4.46M 0.01% 1340
2025
Q2
$19.7M Buy
40,440
+22,449
+125% +$12.8M 0.01% 1046
2025
Q1
$11.1M Buy
17,991
+671
+4% +$381K 0.01% 1355
2024
Q4
$9.18M Sell
17,320
-9,061
-34% -$5.11M 0.01% 1408
2024
Q3
$15.9M Buy
26,381
+7,007
+36% +$3.97M 0.01% 970
2024
Q2
$10.5M Sell
19,374
-7,864
-29% -$4.5M 0.01% 1068
2024
Q1
$17.5M Buy
27,238
+11,201
+70% +$6.8M 0.02% 842
2023
Q4
$9.38M Buy
16,037
+4,706
+42% +$2.63M 0.01% 1058
2023
Q3
$5.89M Sell
11,331
-8,030
-41% -$4.17M 0.01% 1166
2023
Q2
$10.5M Buy
19,361
+2,506
+15% +$1.37M 0.01% 896
2023
Q1
$9.06M Buy
16,855
+3,540
+27% +$1.81M 0.01% 947
2022
Q4
$6.8M Buy
13,315
+7,652
+135% +$3.72M 0.01% 1154
2022
Q3
$2.47M Buy
5,663
+2,346
+71% +$1.13M ﹤0.01% 1817
2022
Q2
$1.56M Sell
3,317
-119
-3% -$58K ﹤0.01% 1911
2022
Q1
$1.74M Buy
3,436
+945
+38% +$453K ﹤0.01% 1933
2021
Q4
$1.32M Sell
2,491
-128
-5% -$61.5K ﹤0.01% 2395
2021
Q3
$1.22M Sell
2,619
-391
-13% -$184K ﹤0.01% 2246
2021
Q2
$1.43M Buy
3,010
+279
+10% +$134K ﹤0.01% 1957
2021
Q1
$1.26M Sell
2,731
-697
-20% -$342K ﹤0.01% 1999
2020
Q4
$1.83M Buy
3,428
+2,426
+242% +$1.19M ﹤0.01% 1672
2020
Q3
$481K Sell
1,002
-17,161
-94% -$8.42M ﹤0.01% 2237
2020
Q2
$8.19M Sell
18,163
-29,410
-62% -$13.1M 0.01% 799
2020
Q1
$20.6M Sell
47,573
-22,371
-32% -$9.99M 0.04% 401
2019
Q4
$30.7M Buy
69,944
+34,617
+98% +$14.6M 0.06% 363
2019
Q3
$14.8M Buy
35,327
+16,968
+92% +$6.93M 0.03% 606
2019
Q2
$6.62M Buy
18,359
+1,295
+8% +$433K 0.01% 920
2019
Q1
$5.46M Sell
17,064
-3,359
-16% -$1.03M 0.01% 960
2018
Q4
$5.79M Sell
20,423
-14,472
-41% -$4.37M 0.01% 853
2018
Q3
$11.2M Buy
34,895
+33,101
+1,845% +$10.5M 0.02% 801
2018
Q2
$577K Sell
1,794
-3,617
-67% -$1.13M ﹤0.01% 1945
2018
Q1
$1.48M Sell
5,411
-1,424
-21% -$377K ﹤0.01% 1516
2017
Q4
$1.66M Sell
6,835
-1,828
-21% -$415K ﹤0.01% 1596
2017
Q3
$1.75M Buy
8,663
+2,377
+38% +$467K ﹤0.01% 1201
2017
Q2
$1.29M Buy
6,286
+2,395
+62% +$477K ﹤0.01% 1423
2017
Q1
$711K Buy
3,891
+39
+1% +$6.8K ﹤0.01% 1540
2016
Q4
$618K Buy
3,852
+383
+11% +$56.3K ﹤0.01% 1576
2016
Q3
$489K Sell
3,469
-2,591
-43% -$361K ﹤0.01% 1224
2016
Q2
$826K Buy
6,060
+2,540
+72% +$337K ﹤0.01% 1271
2016
Q1
$477K Sell
3,520
-1,154
-25% -$156K ﹤0.01% 1214
2015
Q4
$700K Buy
4,674
+699
+18% +$103K ﹤0.01% 1229
2015
Q3
$531K Buy
3,975
+2,108
+113% +$295K ﹤0.01% 1321
2015
Q2
$245K Buy
1,867
+1,455
+353% +$180K ﹤0.01% 1627
2015
Q1
$49.2K Sell
412
-3,879
-90% -$431K ﹤0.01% 1937
2014
Q4
$453K Sell
4,291
-1,194
-22% -$126K ﹤0.01% 1160
2014
Q3
$564K Buy
5,485
+1,119
+26% +$113K ﹤0.01% 1475
2014
Q2
$409K Buy
4,366
+159
+4% +$14.1K ﹤0.01% 1573
2014
Q1
$350K Sell
4,207
-460
-10% -$37.5K ﹤0.01% 1588
2013
Q4
$358K Sell
4,667
-568
-11% -$41.9K ﹤0.01% 1351
2013
Q3
$374K Sell
5,235
-1,330
-20% -$94.6K ﹤0.01% 1763
2013
Q2
$476K Buy
+6,565
New +$482K ﹤0.01% 1597

Other funds holding CHE

BNP Paribas Financial Markets's CHE Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Chemed (CHE) stake by 60% in Q2 2026, buying an estimated $14.4M and bringing the position to 91,254 shares worth $42.5M. The position accounts for 0.01% of the portfolio, ranked #849.

BNP Paribas Financial Markets first reported a position in CHE in Q2 2013 and has held it in 53 quarters since. 497 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • BNP Paribas Financial Markets held 91,254 shares of Chemed worth $42.5M as of Q2 2026.
  • BNP Paribas Financial Markets bought 34,295 Chemed shares in Q2 2026, an estimated $14.4M.
  • Chemed made up 0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #849 holding.
  • BNP Paribas Financial Markets first reported a position in Chemed in Q2 2013 and has held it in 53 quarters since.
  • 497 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.